Bariatric Surgery and Pharmacokinetics of Buprenorphine
NCT ID: NCT03460314
Last Updated: 2023-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
12 participants
OBSERVATIONAL
2016-11-02
2026-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bariatric Surgery and Pharmacokinetics of Chlorprothixene
NCT03449485
Bariatric Surgery and Pharmacokinetics of Methylphenidate
NCT03440190
Bariatric Surgery and Pharmacokinetics of Fluoxetine
NCT03476525
Bariatric Surgery and Pharmacokinetics of Ibuprofen
NCT03476577
Bariatric Surgery and Pharmacokinetics of Gabapentin
NCT03476538
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Buprenorphine
Patients are tested for their normal prescription buprenorphine medication
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Being a Norwegian citizen
Exclusion Criteria
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Olavs Hospital
OTHER
Volvat Medisinsk Senter Stokkan
OTHER
Namsos Hospital
OTHER
Alesund Hospital
OTHER
Norwegian University of Science and Technology
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Magnus Strømmen, MSc
Role: PRINCIPAL_INVESTIGATOR
St. Olavs University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Olavs University Hospital
Trondheim, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Magnus Strømmen, MSc
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/1145g
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.